Research progress on serological indices and their clinical application in rheumatoid arthritis
Shuting Meng,Longxiao Jing,Weiwei Zhang,Feng Wang,Yefeng Dong,Deping Dong
DOI: https://doi.org/10.1002/jcla.24576
IF: 3.124
2022-07-16
Journal of Clinical Laboratory Analysis
Abstract:Figure 1: IL‐38 is involved in RA pathogenesis. As shown in figure 1, keratinocytes and mast cells secrete the pro‐inflammatory cytokines IL‐1 and IL‐33, which activate macrophages to produce IL‐36. Formation of the IL‐38/IL‐36R complex contributes to the recruitment of MyD88, enabling the activation of NF‐κB and MAPKs. figure 2: Various immune cells participate in RA pathogenesis. Various immune cells are involved in RA pathogenesis. As a chronic disease, RA is stimulated by long‐term inflammation and secretes IL‐1β, IL‐6, and TNF‐α, which act on the liver and continuously synthesize SAA. Macrophages abnormally process SAA and act in combination with HS‐GAG and SAP. In the lysosome, SAA and AA are proteolytic ally remodeled by MMPs and finally act on synovial cells. Background As a chronic systemic autoimmune disease of undetermined etiology, rheumatoid arthritis (RA) has a complex pathogenesis, which involves multiple proteins and cytokines. The 2010 ACR/EULAR classification criteria facilitate early diagnosis of RA with reduced specificity when compared to the 1987 ACR criteria. Hence, it is imperative to identify novel serological inflammatory indicators and targets, in order to explain the complex regulatory network of RA. The present review discusses the associations of various inflammatory factors with RA and its underlying mechanism. Besides, the review also provides a novel insight into the clinical treatment of RA. Materials and Methods According to the PRISMA guidelines, databases like Web of Science, Google‐Scholar, Pubmed and Scopus were systematically searched for articles from January 1, 2018 to January 1, 2022 using The following 2 keywords: "rheumatoid arthritis", "Inflammatory cytokines", "ILs", "serum amyloid protein A", "matrix metalloproteinase 3", "RANKL", "Glucose‐6‐phosphoisomerase", "Anti‐keratin antibody", "1,25‐Dihydroxyvitamin D3". Results Indicators like MMPs, ILs, glucose‐6‐phosphate isomerase (GPI), anti‐keratin antibody (AKA) and receptor activator of nuclear factor‐κB ligand (RANKL) are the current hotspots in the efficacy research of RA. The present review suggests that ILs are highly expressed in the serum and synovial tissues of RA patients. By targeted inhibition of ILs with inhibitor application, precise RA treatment can be achieved. Conclusions Based on these results, it can be concluded that inflammatory factors have certain guiding significance in the diagnosis and efficacy evaluation of RA. However, the mechanisms of interactions among them are rather complex, which deserve further exploration.
medical laboratory technology